145 related articles for article (PubMed ID: 33876865)
1. Half of the children with overweight or obesity and attention-deficit/hyperactivity disorder reach normal weight with stimulants.
Fast K; Björk A; Strandberg M; Johannesson E; Wentz E; Dahlgren J
Acta Paediatr; 2021 Oct; 110(10):2825-2832. PubMed ID: 33876865
[TBL] [Abstract][Full Text] [Related]
2. Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder?
Lentferink YE; van de Garde EMW; Knibbe CAJ; van der Vorst MMJ
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):530-536. PubMed ID: 29768018
[TBL] [Abstract][Full Text] [Related]
3. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
[TBL] [Abstract][Full Text] [Related]
4. Co-occurring weight problems among children with attention deficit/hyperactivity disorder: the role of executive functioning.
Graziano PA; Bagner DM; Waxmonsky JG; Reid A; McNamara JP; Geffken GR
Int J Obes (Lond); 2012 Apr; 36(4):567-72. PubMed ID: 22158266
[TBL] [Abstract][Full Text] [Related]
5. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy.
Schneider G; Banaschewski T; Feldman BL; Gustafsson PA; Murphy B; Reynolds M; Coghill DR; Spalding WM
J Child Adolesc Psychopharmacol; 2019 May; 29(4):285-304. PubMed ID: 30942617
[No Abstract] [Full Text] [Related]
6. Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review.
Curtin C; Bandini LG; Perrin EC; Tybor DJ; Must A
BMC Pediatr; 2005 Dec; 5():48. PubMed ID: 16371155
[TBL] [Abstract][Full Text] [Related]
7. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants.
Yackobovitch-Gavan M; Mimouni-Bloch A; Gabbay U; Carmi D; Goldstein B; Keinan-Boker L; Bloch S; Meyerovitch J
J Pediatr; 2021 Nov; 238():296-304.e4. PubMed ID: 34293373
[TBL] [Abstract][Full Text] [Related]
8. The Occurrence of Overweight and Obesity in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder According to Three Different Diagnostic Criteria for Obesity.
Racicka-Pawlukiewicz E; Hanć T; Kuć K; Bielecki M; Zaorska J; Wolańczyk T; Bryńska A
J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):430-438. PubMed ID: 33411571
[No Abstract] [Full Text] [Related]
9. Association between binge eating and attention-deficit/hyperactivity disorder in two pediatric community mental health clinics.
Reinblatt SP; Leoutsakos JM; Mahone EM; Forrester S; Wilcox HC; Riddle MA
Int J Eat Disord; 2015 Jul; 48(5):505-11. PubMed ID: 25130278
[TBL] [Abstract][Full Text] [Related]
10. Body mass index of children with attention-deficit/hyperactivity disorder.
Dubnov-Raz G; Perry A; Berger I
J Child Neurol; 2011 Mar; 26(3):302-8. PubMed ID: 20929910
[TBL] [Abstract][Full Text] [Related]
11. Attention-Deficit/Hyperactivity Disorder is Related to Decreased Weight in the Preschool Period and to Increased Rate of Overweight in School-Age Boys.
Hanć T; Słopień A; Wolańczyk T; Szwed A; Czapla Z; Durda M; Dmitrzak-Węglarz M; Ratajczak J
J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):691-700. PubMed ID: 26401547
[TBL] [Abstract][Full Text] [Related]
12. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
Rose SR; Reeves G; Gut R; Germak J
J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate and Reduced Overweight in Children With ADHD.
Mellström E; Forsman C; Engh L; Hallerbäck MU; Wikström S
J Atten Disord; 2020 Jan; 24(2):246-254. PubMed ID: 30371133
[No Abstract] [Full Text] [Related]
14. Thyroid Hormone Status in Overweight Children with Attention Deficit/Hyperactivity Disorder.
Langrock C; Hebebrand J; Radowksi K; Hamelmann E; Lücke T; Holtmann M; Legenbauer T; Schmidt B; Frank M; Jöckel KH; Reinehr T
Horm Res Paediatr; 2018; 89(3):150-156. PubMed ID: 29320782
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity.
Kollin SR; Lim CS; Lee AA
Pediatr Obes; 2023 Sep; 18(9):e13058. PubMed ID: 37263740
[TBL] [Abstract][Full Text] [Related]
17. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.
Troksa K; Kovacich N; Moro M; Chavez B
Pharmacotherapy; 2019 Jun; 39(6):665-676. PubMed ID: 30368860
[TBL] [Abstract][Full Text] [Related]
18. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
[TBL] [Abstract][Full Text] [Related]
19. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
[TBL] [Abstract][Full Text] [Related]
20. Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis.
Biederman J; DiSalvo M; Green A; Hutt Vater C; Driscoll H; Faraone SV
J Dev Behav Pediatr; 2023 Feb-Mar 01; 44(2):e80-e87. PubMed ID: 36750982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
